BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//thebench.bio//Events//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:event-114@thebench.bio
DTSTAMP:20261011T090430Z
DTSTART;VALUE=DATE:20270222
DTEND;VALUE=DATE:20270226
SUMMARY:Antibodies as Drugs: Evolving Designs\, Formats and Approaches (Key
 stone K7)
LOCATION:Fairmont Banff Springs\, Banff\, AB\, Canada
DESCRIPTION:Forty years after the first therapeutic monoclonal antibody was
  approved\, this Keystone Symposia meeting in Banff asks where antibody dr
 ugs go next. Sessions cover multispecifics\, conditionally active and sele
 ctively engaging platforms\, pathogen targets\, novel scaffolds and antibo
 dy-like formats\, with organisers from Vanderbilt\, Third Rock Ventures an
 d Eli Lilly. A joint session with the computational drug discovery meeting
  running alongside it adds breadth\, and trainees can join a career roundt
 able. Livestream and on-demand options are offered.\n\nhttps://www.keyston
 esymposia.org/conferences/conference-listing/meeting/k72027
URL:https://thebench.bio/events/antibodies-as-drugs-evolving-designs-format
 s-and-approaches-keystone-k7-2027
END:VEVENT
END:VCALENDAR